BASSETTI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 40.543
Totale 40.543
Nazione #
IT - Italia 40.543
Totale 40.543
Città #
Genova 21.918
Genoa 11.270
Vado Ligure 3.671
Rapallo 3.571
Bordighera 113
Totale 40.543
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 283
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 256
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 221
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. 203
Mould Infections of Traumatic Wounds: A Brief Narrative Review 195
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 189
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 169
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 160
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 157
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 157
An Italian consensus for invasive candidiasis management (ITALIC). 156
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 156
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 156
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 155
Use of colistin in adult patients: a cross-sectional study 153
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 152
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 150
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. 149
Invasive candidiasis in non-hematological patients. 149
Possible malignant transformation of benign lymphoepithelial parotid lesions in human immunodeficiency virus-infected patients: report of three cases. 149
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 147
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. 146
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 145
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 143
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 142
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 142
Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. 142
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 142
Artificial intelligence and prescription of antibiotic therapy: present and future 140
A case report of Absidia corymbifera soft-tissue infection with kidney involvement in a AIDS patient. 139
Will new antimicrobials overcome resistance among Gram-negatives? 138
Current status of newer carbapenems 134
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 133
Monitoraggio della gestione pre ed intra-operatoria del paziente sottoposto ad intervento chirurgico presso l’A.O.U. San Martino di Genova 132
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 132
Management of KPC-producing Klebsiella pneumoniae infections 132
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children 131
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). 131
Candidaemia in internal medicine departments: the burden of a rising problem. 131
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 131
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 131
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 131
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration 130
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 130
Infective endocarditis in elderly: An Italian prospective multi-center observational study 129
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 129
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 129
Primary varicella zoster infection associated with fingolimod treatment. 128
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 128
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 128
High-dose daptomycin in documented Staphylococcus aureus infections. 127
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 126
Treatment of Infections Due to MDR Gram-Negative Bacteria 125
Sequentialoutbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation 124
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy 124
Tigecycline use in serious nosocomial infections: a drug use evaluation. 123
Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy? 121
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 121
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 120
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 120
Clinical and therapeutic aspects of candidemia: A five year single centre study 120
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 120
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 119
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 118
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 117
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 117
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 116
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 116
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 116
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 115
Analysis of clinical data in patients with Girldstone arthroplasty: a new score 114
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 114
Bloodstream infections in critically ill patients with COVID-19 114
Hospital-Acquired Infections and Leading Pathogens Detected in a Regional University Adult Acute-care Hospital in Genoa, Liguria, Italy: Results from a Prevalence Study 113
Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort. 113
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study-authors' response 113
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 113
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 113
Novel beta-lactam antibiotics and inhibitor combinations. Expert Opin Investig Drugs 112
Soft-tissue infection with Absidia corymbifera and kidney complications in an AIDS patient. 112
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. 112
Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects 112
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 112
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 112
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 111
Antimicrobial use and resistance among gram-negative bacilli in an italian intensive care unit (ICU) 111
Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies 111
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B 110
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. 110
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 110
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 110
Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study 110
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 109
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 109
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 109
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 108
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections 108
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 108
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 107
Epidemiological trends in nosocomial candidemia in intensive care 106
Totale 13.292
Categoria #
all - tutte 171.975
article - articoli 169.383
book - libri 0
conference - conferenze 845
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.747
Totale 343.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.615 219 558 454 365 358 289 283 509 360 638 255 327
2021/20225.251 247 176 192 533 168 381 384 1.166 645 428 266 665
2022/20234.540 558 328 55 385 575 603 139 314 822 216 440 105
2023/20242.874 137 326 79 320 234 411 185 181 152 111 222 516
2024/202510.217 235 738 236 523 1.402 1.020 985 1.377 497 567 965 1.672
2025/20261.302 1.302 0 0 0 0 0 0 0 0 0 0 0
Totale 41.854